Hoth Therapeutics Statistics
Total Valuation
HOTH has a market cap or net worth of $4.47 million. The enterprise value is -$3.04 million.
| Market Cap | 4.47M |
| Enterprise Value | -3.04M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, after market close.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
HOTH has 5.36 million shares outstanding. The number of shares has increased by 77.17% in one year.
| Shares Outstanding | 5.36M |
| Shares Change (YoY) | +77.17% |
| Shares Change (QoQ) | +29.03% |
| Owned by Insiders (%) | 0.80% |
| Owned by Institutions (%) | 10.09% |
| Float | 4.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.57 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.14, with a Debt / Equity ratio of 0.01.
| Current Ratio | 13.14 |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -83.00% and return on invested capital (ROIC) is -95.85%.
| Return on Equity (ROE) | -83.00% |
| Return on Assets (ROA) | -73.30% |
| Return on Capital (ROIC) | -95.85% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.57M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.74% in the last 52 weeks. The beta is 0.80, so HOTH's price volatility has been lower than the market average.
| Beta (5Y) | 0.80 |
| 52-Week Price Change | -68.74% |
| 50-Day Moving Average | 1.00 |
| 200-Day Moving Average | 1.21 |
| Relative Strength Index (RSI) | 43.12 |
| Average Volume (20 Days) | 1,965,088 |
Short Selling Information
The latest short interest is 56,778, so 1.06% of the outstanding shares have been sold short.
| Short Interest | 56,778 |
| Short Previous Month | 76,067 |
| Short % of Shares Out | 1.06% |
| Short % of Float | 1.29% |
| Short Ratio (days to cover) | 1.44 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.55M |
| Pretax Income | -7.70M |
| Net Income | -7.70M |
| EBITDA | -7.70M |
| EBIT | -7.70M |
| Earnings Per Share (EPS) | -$1.94 |
Balance Sheet
The company has $7.56 million in cash and $48,222 in debt, giving a net cash position of $7.51 million or $1.40 per share.
| Cash & Cash Equivalents | 7.56M |
| Total Debt | 48,222 |
| Net Cash | 7.51M |
| Net Cash Per Share | $1.40 |
| Equity (Book Value) | 7.83M |
| Book Value Per Share | 1.46 |
| Working Capital | 7.77M |
Cash Flow
| Operating Cash Flow | -7.88M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.88M |
| FCF Per Share | -$1.79 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HOTH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -77.17% |
| Shareholder Yield | -77.17% |
| Earnings Yield | -172.20% |
| FCF Yield | -176.20% |
Analyst Forecast
The average price target for HOTH is $6.17, which is 639.19% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.17 |
| Price Target Difference | 639.19% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 26, 2022. It was a reverse split with a ratio of 1:25.
| Last Split Date | Oct 26, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |